Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Schell

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
JAMA Oncology|October 22, 2020
Need for More Comprehensive Evaluation of Immune-Related Adverse Events in Immunotherapy for Biliary Tract Cancer-ReplyDae Won Kim, Michael J Schell, Richard D Kim
Traffic (Copenhagen, Denmark)|September 23, 2014
Copper directs ATP7B to the apical domain of hepatic cells via basolateral endosomesLydia K Nyasae, Michael J Schell, Ann L Hubbard
Frontiers in Neurology|October 27, 2015
Transplanted Neural Progenitor Cells from Distinct Sources Migrate Differentially in an Organotypic Model of Brain InjuryKapinga P Ngalula, Nathan Cramer, Michael J Schell, et al.
Molecular Biology of the Cell|December 31, 2003
Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cellsAija Kyttälä, Gudrun Ihrke, Jouni Vesa, et al.
Journal of Cell Science|January 30, 2016
Myosin Vb mediates Cu+ export in polarized hepatocytesArnab Gupta, Michael J Schell, Ashima Bhattacharjee, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancerThomas A Hensing, Michael J Schell, Ji-Hyun Lee, et al.
Statistics in Medicine|December 13, 2021
Determination of the number of observers needed to evaluate a subjective test and its application in two PD-L1 studiesGang Han, Michael J Schell, Emily S Reisenbichler, et al.
Scientific Reports|July 28, 2023
Techniques to produce and evaluate realistic multivariate synthetic dataJohn Heine, Erin E E Fowler, Anders Berglund, et al.
Oncotarget|April 16, 2020
A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomyNagi B Kumar, Julio Pow-Sang, Philippe Spiess, et al.
Bioinformatics (Oxford, England)|May 5, 2017
SinCHet: a MATLAB toolbox for single cell heterogeneity analysis in cancerJiannong Li, Inna Smalley, Michael J Schell, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
JAMA Oncology|October 22, 2020
Need for More Comprehensive Evaluation of Immune-Related Adverse Events in Immunotherapy for Biliary Tract Cancer-ReplyDae Won Kim, Michael J Schell, Richard D Kim
Traffic (Copenhagen, Denmark)|September 23, 2014
Copper directs ATP7B to the apical domain of hepatic cells via basolateral endosomesLydia K Nyasae, Michael J Schell, Ann L Hubbard
Frontiers in Neurology|October 27, 2015
Transplanted Neural Progenitor Cells from Distinct Sources Migrate Differentially in an Organotypic Model of Brain InjuryKapinga P Ngalula, Nathan Cramer, Michael J Schell, et al.
Molecular Biology of the Cell|December 31, 2003
Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cellsAija Kyttälä, Gudrun Ihrke, Jouni Vesa, et al.
Journal of Cell Science|January 30, 2016
Myosin Vb mediates Cu+ export in polarized hepatocytesArnab Gupta, Michael J Schell, Ashima Bhattacharjee, et al.
Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancerThomas A Hensing, Michael J Schell, Ji-Hyun Lee, et al.
Statistics in Medicine|December 13, 2021
Determination of the number of observers needed to evaluate a subjective test and its application in two PD-L1 studiesGang Han, Michael J Schell, Emily S Reisenbichler, et al.
Scientific Reports|July 28, 2023
Techniques to produce and evaluate realistic multivariate synthetic dataJohn Heine, Erin E E Fowler, Anders Berglund, et al.
Oncotarget|April 16, 2020
A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomyNagi B Kumar, Julio Pow-Sang, Philippe Spiess, et al.
Bioinformatics (Oxford, England)|May 5, 2017
SinCHet: a MATLAB toolbox for single cell heterogeneity analysis in cancerJiannong Li, Inna Smalley, Michael J Schell, et al.
Pageof 16